Your browser doesn't support javascript.
loading
Tocilizumab monotherapy uncovered the role of the CCL22/17-CCR4+ Treg axis during remission of crescentic glomerulonephritis.
Sakai, Ryota; Ito, Minako; Yoshimoto, Keiko; Chikuma, Shunsuke; Kurasawa, Takahiko; Kondo, Tsuneo; Suzuki, Katsuya; Takeuchi, Tsutomu; Amano, Koichi; Yoshimura, Akihiko.
Afiliação
  • Sakai R; Department of Microbiology and Immunology Keio University School of Medicine Tokyo Japan.
  • Ito M; Department of Rheumatology and Clinical Immunology Saitama Medical Center Saitama Medical University Kawagoe Japan.
  • Yoshimoto K; Department of Microbiology and Immunology Keio University School of Medicine Tokyo Japan.
  • Chikuma S; Division of Rheumatology Department of Internal Medicine Keio University School of Medicine Tokyo Japan.
  • Kurasawa T; Department of Microbiology and Immunology Keio University School of Medicine Tokyo Japan.
  • Kondo T; Department of Rheumatology and Clinical Immunology Saitama Medical Center Saitama Medical University Kawagoe Japan.
  • Suzuki K; Department of Rheumatology and Clinical Immunology Saitama Medical Center Saitama Medical University Kawagoe Japan.
  • Takeuchi T; Division of Rheumatology Department of Internal Medicine Keio University School of Medicine Tokyo Japan.
  • Amano K; Division of Rheumatology Department of Internal Medicine Keio University School of Medicine Tokyo Japan.
  • Yoshimura A; Department of Rheumatology and Clinical Immunology Saitama Medical Center Saitama Medical University Kawagoe Japan.
Clin Transl Immunology ; 9(11): e1203, 2020.
Article em En | MEDLINE | ID: mdl-33163184

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Transl Immunology Ano de publicação: 2020 Tipo de documento: Article País de publicação: Austrália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Transl Immunology Ano de publicação: 2020 Tipo de documento: Article País de publicação: Austrália